- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Esaote posts higher 1998 results
Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical,
Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical, which Esaote bought from Philips Medical Systems last year (SCAN 4/29/98). Esaote also posted robust international sales of $121.5 million, up 42% from $85.5 million in 1997. The company's international revenues accounted for 60% of its total sales.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
